Extrathymic tumors in patients with myasthenia gravis: A 35-year retrospective study

Neurologist

Volumn 12, Issue 1, 2006, Pages 53-55

  Wakata, Nobuo ^a   Sugimoto, Hideki ^a   Nomoto, Nobuatsu ^a   Konno, Singo ^a   Nakazora, Hiroshi ^a   Nemoto, Hiroshi ^a   Karihara, Teruyuki ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Extrathymic tumor; Myasthenia gravis; Tumor risk

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CANCER LOCALIZATION; CANCER RISK; EXTRATHYMIC TUMOR; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THYMUS CANCER;

ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THYMUS GLAND; TREATMENT OUTCOME;

EID: 33646481205     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000195828.36108.c3     Document Type: Article

References (16)

1. Miller D. The association of immune disease and malignant lymphoma. Ann Intern Med. 1990;66:507-521.
2. Oosterhuis HJGH. Myasthenia Gravis. Edinburgh: Churchill Livingston; 1984.
3. Penn I. Cancer complicating organ transplantation. N Engl J Med. 1990;323:1767-1769.
4. Confavreux C, Saddier P, Grimaud J, et al. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology. 1996;46:1607-1612.
5. Alper LI, Papatestas A, Kark A, et al. A histological reappraisal of the thymus in myasthenia-gravis: a correlative study of thymic pathology and response to thymectomy. Arch Pathol. 1971;91:55-61.
6. Papatestas AE, Osserman KE, Kark AE. The relationship between thymus and oncogenesis: a study of the incidence of non thymic malignancy in myasthenia gravis. Br J Cancer. 1971;25:635-645.
7. Vessey MP, Doll R, Noman-Smith B, et al. Thymectomy and cancer: a further report. Br J Cancer. 1979;39:193-195.
8. Goulon M, Estournet B, Tulliez M. Myasthenia gravis and associated disease. Int J Neurol. 1980;14:61-72.
9. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci. 1981;377:678-690.
10. Monden Y, Uyama T, Kimura S, et al. Extrathymic malignancy in patients with myasthenia gravis. Eur J Cancer. 1991;27:745-747.
11. Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg. 1994;8:251-253.
12. Ben Hur T, Lossos A, Abramsky O, et al. Extrathymic tumor in patients with myasthenia gravis. Neurology. 1995;45(suppl 4):A353.
13. Evoli A, Batocchi AP, Tonali P, et al. Risk of cancer in patients with myasthenia gravis. Ann N Y Acad Sci. 1998;841:742-745.
14. Hasegawa S, Nishiyama H, Tanaka K, et al. Welfare Statistic Association. [Japanese]. J Health Welfare Stat. 2004;51:417.
15. Ariad S, Geffen DB, Yanai-Inbar I, et al. Myasthenia gravis associated with malignancy mixed Mullerian tumor of the Uterus. Gynecol Oncol. 1997;64:510-515.
16. Abrey LE, Askanas V. Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy. Neurology. 1995;45:1019.